Inhibikase Therapeutics
IKT
IKT
14 hedge funds and large institutions have $2.69M invested in Inhibikase Therapeutics in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$60.2K | |
| 2 | +$42.9K | |
| 3 | +$41K | |
| 4 |
AC
Armistice Capital
New York
|
+$11K |
| 5 |
Renaissance Technologies
New York
|
+$5.44K |
Top Sellers
| 1 | -$37.9K | |
| 2 | -$25.7K | |
| 3 | -$22.9K | |
| 4 |
CWM
CCG Wealth Management
San Diego,
California
|
-$19.7K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$19K |